MEF2D Antikörper (AA 431-521)
-
- Target Alle MEF2D Antikörper anzeigen
- MEF2D (Myocyte Enhancer Factor 2D (MEF2D))
-
Bindungsspezifität
- AA 431-521
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser MEF2D Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Verwendungszweck
- MEF2D Rabbit pAb
- Sequenz
- TTHPHISIKS EPVSPSRERS PAPPPPAVFP AARPEPGDGL SSPAGGSYET GDRDDGRGDF GPTLGLLRPA PEPEAEGSAV KRMRLDTWTL K
- Kreuzreaktivität
- Human, Maus
- Produktmerkmale
- Polyclonal Antibodies
- Aufreinigung
- Affinity purification
- Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 431-521 of human MEF2D (NP_005911.1).
- Isotyp
- IgG
- Top Product
- Discover our top product MEF2D Primärantikörper
-
anti-Myocyte Enhancer Factor 2D (MEF2D) (AA 299-509) antibody
MEF2D Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Myocyte Enhancer Factor 2D (MEF2D) (AA 1-521) antibodyMEF2D Reaktivität: Human WB, IF Wirt: Maus Polyclonal unconjugated
anti-Myocyte Enhancer Factor 2D (MEF2D) (AA 256-351) antibodyMEF2D Reaktivität: Human WB, ELISA, IF Wirt: Maus Monoclonal 3A11 unconjugated
anti-Myocyte Enhancer Factor 2D (MEF2D) (AA 346-511) antibodyMEF2D Reaktivität: Human, Maus, Ratte, Hund WB, IHC, IF, IP Wirt: Maus Monoclonal 9-MEF2D unconjugated
anti-Myocyte Enhancer Factor 2D (MEF2D) (AA 1-110) antibodyMEF2D Reaktivität: Maus WB, ELISA, IF (cc), IF (p), IHC (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Myocyte Enhancer Factor 2D (MEF2D) antibodyMEF2D Reaktivität: Human, Maus, Ratte ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Myocyte Enhancer Factor 2D (MEF2D) (AA 1-521) antibodyMEF2D Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Myocyte Enhancer Factor 2D (MEF2D) (AA 256-351) antibodyMEF2D Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 4D6 unconjugated
anti-Myocyte Enhancer Factor 2D (MEF2D) (AA 256-351) antibodyMEF2D Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 1B8 unconjugated
anti-Myocyte Enhancer Factor 2D (MEF2D) (AA 346-511) antibodyMEF2D Reaktivität: Human, Maus, Ratte, Hund WB, IHC, IF, IP Wirt: Maus Monoclonal 9-MEF2D unconjugated
-
- Applikationshinweise
- WB,1:500 - 1:2000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- MEF2D (Myocyte Enhancer Factor 2D (MEF2D))
- Andere Bezeichnung
- MEF2D (MEF2D Produkte)
- Synonyme
- sl1 antikoerper, sl-1 antikoerper, XMEF2D antikoerper, MGC145245 antikoerper, C80750 antikoerper, myocyte enhancer factor 2D antikoerper, MADS box transcription enhancer factor 2, polypeptide D (myocyte enhancer factor 2D) antikoerper, mef2d antikoerper, MEF2D antikoerper, Mef2d antikoerper
- Hintergrund
- This gene is a member of the myocyte-specific enhancer factor 2 (MEF2) family of transcription factors. Members of this family are involved in control of muscle and neuronal cell differentiation and development, and are regulated by class II histone deacetylases. Fusions of the encoded protein with Deleted in Azoospermia-Associated Protein 1 (DAZAP1) due to a translocation have been found in an acute lymphoblastic leukemia cell line, suggesting a role in leukemogenesis. The encoded protein may also be involved in Parkinson disease and myotonic dystrophy. Alternative splicing results in multiple transcript variants.,MEF2D,Epigenetics & Nuclear Signaling,Transcription Factors,Signal Transduction,ErbB-HER Signaling Pathway,MAPK-P38 Signaling Pathway,Endocrine & Metabolism,AMPK Signaling Pathway,Neuroscience,Cardiovascular,Heart,Cardiogenesis,Hypertrophy,MEF2D
- Molekulargewicht
- 49kDa/50kDa/55kDa/56kDa
- Gen-ID
- 4209
- UniProt
- Q14814
-
